Document Detail

Resveratrol in the prevention and treatment of coronary artery disease.
MedLine Citation:
PMID:  21870059     Owner:  NLM     Status:  MEDLINE    
Resveratrol is a polyphenolic compound found in red wine that is believed to be responsible for its beneficial cardiovascular effects. Extensive research in the past several decades has identified multiple mechanisms by which resveratrol modifies the cardiovascular risk factors that lead to coronary artery disease, yet translation to the clinical arena has been unexpectedly slow. In this article, we review the existing evidence regarding the beneficial effects of resveratrol and briefly discuss its potential therapeutic applications.
Louis M Chu; Antonio D Lassaletta; Michael P Robich; Frank W Sellke
Related Documents :
16844629 - Three-vessel coronary artery disease, aortic stenosis, and constrictive pericarditis 27...
20447039 - Aortic valve surgery in congenital heart disease: a single-center experience.
16551359 - Validation of the severity index by cardiac catheterization and doppler echocardiograph...
16022969 - Direct-access valve replacement a novel approach for off-pump valve implantation using ...
2009569 - Left ventricular mid-cavitary obstruction after balloon dilation in isolated aortic val...
10971029 - Stroke as the first manifestation of calcific aortic stenosis.
1563409 - Initial clinical experience with a new pulsed dye laser device in angioplasty of limb i...
19225399 - Nonrevascularizable coronary artery disease following coronary artery bypass graft surg...
21620649 - Challenging neck anatomy is associated with need for intraoperative endovascular adjunc...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current atherosclerosis reports     Volume:  13     ISSN:  1534-6242     ISO Abbreviation:  Curr Atheroscler Rep     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-11-02     Completed Date:  2012-02-21     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  100897685     Medline TA:  Curr Atheroscler Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  439-46     Citation Subset:  IM    
Division of Cardiothoracic Surgery, Department of Surgery, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiovascular System / drug effects
Coronary Artery Disease / physiopathology,  prevention & control*,  therapy
Lipid Peroxidation
Lipids / blood
Macrophages / physiology
Metabolic Syndrome X / physiopathology,  therapy
Muscle, Smooth, Vascular / physiology
Myocardial Reperfusion
Plaque, Atherosclerotic / physiopathology
Stilbenes / therapeutic use*
Thrombosis / physiopathology
Reg. No./Substance:
0/Lipids; 0/Stilbenes; Q369O8926L/resveratrol
Erratum In:
Curr Atheroscler Rep. 2011 Dec;13(6):508

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Correlation of SATB1 overexpression with the progression of human rectal cancer.
Next Document:  Effects of Dietary Factors on Lipoprotein-Associated Phospholipase A(2) (Lp-PLA (2)).